Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Surg Oncol. 2013 Oct 28;109(2):158–167. doi: 10.1002/jso.23470

Fig. 4.

Fig. 4

A 37-year-old patient with HR-negative and HER2-positive non-mass-like lesion (invasive ductal cancer). The maximum intensity projection (MIP) images of pretreatment, F/U-1, and final MRI are shown. MRI shows a complete response and the pathology shows pCR. Although this is a non-mass lesion, the diagnosis of MRI in HR-negative and HER2-positive tumor that receives trastuzumab is highly accurate. This is a true negative case.